Innoviva, Inc.

INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001080014

Price chart

Open-market purchases and sales by INVA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Nov 17, 2023Nov 15, 2023Zhen MarianneChief Accounting OfficerSSaleCommon Stock−10.99K$13.9903−$153.81K40.16K−21.5%SEC
Jun 20, 20239:00 PM ETJun 15, 2023DENNER ALEXANDER J and 1 other10% OwnerPPurchaseCommon Stock, par value $0.01 per share+62K$13.1322+$814.2K7.28M+0.9%SEC
Jun 7, 20238:10 PM ETJun 5 – Jun 6, 2023DENNER ALEXANDER J and 1 other10% OwnerPPurchaseCommon Stock, par value $0.01 per share+15K$13.0454+$195.68K7.22M+0.2%SEC
May 30, 20237:01 PM ETMay 25 – May 30, 2023DENNER ALEXANDER J and 1 other10% OwnerPPurchaseCommon Stock, par value $0.01 per share+200K$13.0435+$2.61M7.2M+2.9%SEC
May 19, 20239:12 PM ETAmendedMay 17 – May 19, 2023DENNER ALEXANDER J and 1 other10% OwnerPPurchaseCommon Stock, par value $0.01 per share+96K$13.2227+$1.27M7M+1.4%SEC

The largest institutional positions in INVA at the end of Q2 2026.

Institutions holding INVA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.11,555,209$267.96M0.00%+247,364+2.2%Added
DIMENSIONAL FUND ADVISORS LP4,494,053$102.06M0.02%+57,626+1.3%Added
VANGUARD PORTFOLIO MANAGEMENT LLC4,220,273$95.84M0.00%−4,678−0.1%Reduced
RENAISSANCE TECHNOLOGIES LLC4,036,532$91.67M0.13%−19,100−0.5%Reduced
STATE STREET CORP3,268,004$74.22M0.00%+207,627+6.8%Added